Growth Metrics

Collegium Pharmaceutical (COLL) Goodwill & Intangibles (2016 - 2026)

Collegium Pharmaceutical has reported Goodwill & Intangibles over the past 10 years, most recently at $815.4 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 22.61% year-over-year to $815.4 million; the TTM value through Dec 2025 reached $815.4 million, down 22.61%, while the annual FY2025 figure was $815.4 million, 22.61% down from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $815.4 million at Collegium Pharmaceutical, down from $870.9 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $1.1 billion in Q3 2024 and troughed at $268.7 million in Q4 2021.
  • A 5-year average of $710.8 million and a median of $739.3 million in 2022 define the central range for Goodwill & Intangibles.
  • Biggest five-year swings in Goodwill & Intangibles: skyrocketed 280.45% in 2022 and later tumbled 55.16% in 2024.
  • Year by year, Goodwill & Intangibles stood at $268.7 million in 2021, then soared by 160.92% to $701.2 million in 2022, then dropped by 20.77% to $555.6 million in 2023, then surged by 89.67% to $1.1 billion in 2024, then fell by 22.61% to $815.4 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for COLL at $815.4 million in Q4 2025, $870.9 million in Q3 2025, and $928.4 million in Q2 2025.